Is BIIB up or down today?
BIIB is up 0.60% today, last at 206.85. This stock moved +0.60% versus the prior close.
BIIB · Biogen
BIIB (Biogen) is trading at 206.85, up 0.60% on the session. Price action and momentum indicators lean constructive.
Over the past 7 days, 30 headlines skew mostly positive. Earnings and Guidance themes dominated coverage. Stories with measurable price impact averaged +2.35% — the market reacted positively.
Social mentions lean cautious or negative.
Analyst firms are mostly reiterating — no strong directional shift lately.
BIIB is up 0.60% today, last at 206.85. This stock moved +0.60% versus the prior close.
Over the past 7 days, 30 headlines skew mostly positive. Earnings and Guidance themes dominated coverage. Stories with measurable price impact averaged +2.35% — the market reacted positively. Dominant story: Oppenheimer reiterates Biogen stock rating on strong quarter By Investing.com - Investing.com Canada (1 source, bullish) RSI is 54 — neutral Price above 50-day average — short-term uptrend Social (demo): 40% of recent mentions lean bullish — social mood is cautious.
Loaded: Jan 2026 – Jul 2026 (124 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Query: Biogen
57/ 100 index
+11.8% vs start of window
Based on 11,133 mentions over 30d
Oppenheimer reiterates Biogen stock rating on strong quarter By Investing.com - Investing.com Canada
Biogen Boosts Profit Forecast with Growth Across Alzheimer's, Rare Disease Portfolio - Benzinga
Wedbush Adjusts Biogen Price Target to $215 From $201, Maintains Neutral Rating
Stifel Nicolaus Adjusts Biogen Price Target to $242 From $214 - marketscreener.com
Stifel Nicolaus Adjusts Biogen Price Target to $242 From $214